Position in INDV
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,311,328
New position
Shares Held
75,831
first reported quarter
Ownership
0.062%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
344,903 | $40,770,982 | |
| 2 | VTRS |
Viatris Inc
|
1,045,698 | $14,127,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,878 | $5,264,475 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
75,831 | $2,311,328 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
17,011 | $2,241,028 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91,785 | $2,196,415 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
55,414 | $1,669,069 | |
| 8 | ALKS |
Alkermes plc.
|
5,106 | $180,548 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,311,328 | 75,831 | Shares | Defined | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||